Gossamer Bio (GOSS) Return on Sales [ROS] (2024 - 2026)
Gossamer Bio's Return on Sales [ROS] came in at -282.25% for Q2 2026, up 55.16 percentage points from -337.41% a year earlier but down 17.63 percentage points from the prior quarter.
Powered by 
Analysis
Gossamer Bio (GOSS) Return on Sales [ROS] (2024 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Gossamer Bio reported Return on Sales [ROS] of -311.70%, up 50.21 percentage points year-over-year; for FY2025, it came in at -352.23%, down 299.99 percentage points from FY2024.
- Going back by year, Return on Sales [ROS] was -52.24% in FY2024.
- The five-year range for quarterly Return on Sales [ROS] is -385.20% (Q4 2024) to 54.35% (Q2 2024).
- Year-over-year, Return on Sales [ROS] has increased for three consecutive quarters, with an average year-over-year change of -37.81 percentage points over the last five quarters.
- Business Quant data shows GOSS's Return on Sales [ROS] at -264.62% (Q1 2026), -333.64% (Q4 2025) and -369.44% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,140.91 Bn | 1,109.50 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 634.46 Bn | 554.32 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 500.42 Bn | 473.54 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 355.19 Bn | 309.56 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 300.18 Bn | 264.17 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 263.17 Bn | 236.86 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 237.83 Bn | 193.23 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 193.81 Bn | 168.01 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 170.12 Bn | 116.76 Bn | 10.94 Bn | 28.37% |
| 10 | Gossamer Bio | 36.50 Mn | -436.90 Mn | - | -282.25% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -282.25% |
| Mar 31, 2026 | -264.62% |
| Dec 31, 2025 | -333.64% |
| Sep 30, 2025 | -369.44% |
| Jun 30, 2025 | -337.41% |
| Mar 31, 2025 | -372.23% |
| Dec 31, 2024 | -385.20% |
| Sep 30, 2024 | -357.80% |
| Jun 30, 2024 | 54.35% |
API Access
Gossamer Bio Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=GOSS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "GOSS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=GOSS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();